Literature DB >> 11353557

Inflammation in the cardia.

M Voutilainen1, P Sipponen.   

Abstract

The detection of chronic inflammation and intestinal metaplasia at the gastric side of a normal-appearing esophagogastric junction started active research on gastric cardia pathology. The main causes for this interest have been the increasing incidence of gastroesophageal reflux disease (GERD) and cardia adenocarcinoma. Many controversies still exist. It is even controversial whether noninflamed gastric cardia epithelium is a normal structure present at birth or an acquired lesion as a consequence of GERD. Similarly, the pathogenesis of chronic inflammation and intestinal metaplasia of gastric cardia are a matter of debate. Some researchers consider these lesions to be a consequence of Helicobacter pylori infection, whereas others think that chronic cardia inflammation and intestinal metaplasia are consequences of GERD. In this paper we review recent published studies in this field.

Entities:  

Mesh:

Year:  2001        PMID: 11353557     DOI: 10.1007/s11894-001-0024-5

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  24 in total

1.  The location and frequency of intestinal metaplasia at the esophagogastric junction in 223 consecutive autopsies: implications for patient treatment and preventive strategies in Barrett's esophagus.

Authors:  A H Ormsby; S P Kilgore; J R Goldblum; J E Richter; T W Rice; T L Gramlich
Journal:  Mod Pathol       Date:  2000-06       Impact factor: 7.842

Review 2.  The role of gastric carditis in metaplasia and neoplasia at the gastroesophageal junction.

Authors:  S J Spechler
Journal:  Gastroenterology       Date:  1999-07       Impact factor: 22.682

3.  Histology of the gastroesophageal junction: an autopsy study.

Authors:  P T Chandrasoma; R Der; Y Ma; P Dalton; M Taira
Journal:  Am J Surg Pathol       Date:  2000-03       Impact factor: 6.394

4.  Classical Barrett esophagus contrasted with Barrett-type epithelium at normal-appearing esophagogastric junction. Central Finland Endoscopy Study Group.

Authors:  M Voutilainen; M Färkkilä; J P Mecklin; M Juhola; P Sipponen
Journal:  Scand J Gastroenterol       Date:  2000-01       Impact factor: 2.423

5.  Gastroesophageal reflux disease: prevalence, clinical, endoscopic and histopathological findings in 1,128 consecutive patients referred for endoscopy due to dyspeptic and reflux symptoms.

Authors:  M Voutilainen; P Sipponen; J P Mecklin; M Juhola; M Färkkilä
Journal:  Digestion       Date:  2000       Impact factor: 3.216

6.  Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries.

Authors:  A A Botterweck; L J Schouten; A Volovics; E Dorant; P A van Den Brandt
Journal:  Int J Epidemiol       Date:  2000-08       Impact factor: 7.196

7.  Inflammation and specialized intestinal metaplasia of cardiac mucosa is a manifestation of gastroesophageal reflux disease.

Authors:  S Oberg; J H Peters; T R DeMeester; P Chandrasoma; J A Hagen; A P Ireland; M P Ritter; R J Mason; P Crookes; C G Bremner
Journal:  Ann Surg       Date:  1997-10       Impact factor: 12.969

8.  The gastric cardia in gastro-oesophageal disease.

Authors:  H M el-Zimaity; V J Verghese; J Ramchatesingh; D Y Graham
Journal:  J Clin Pathol       Date:  2000-08       Impact factor: 3.411

9.  Association between body mass and adenocarcinoma of the esophagus and gastric cardia.

Authors:  J Lagergren; R Bergström; O Nyrén
Journal:  Ann Intern Med       Date:  1999-06-01       Impact factor: 25.391

10.  The gastric cardia: fact or fiction?

Authors:  S P Kilgore; A H Ormsby; T L Gramlich; T W Rice; J E Richter; G W Falk; J R Goldblum
Journal:  Am J Gastroenterol       Date:  2000-04       Impact factor: 10.864

View more
  1 in total

1.  Age, smoking and overweight contribute to the development of intestinal metaplasia of the cardia.

Authors:  Christian Felley; Hanifa Bouzourene; Marianne Bründler G VanMelle; Antoine Hadengue; Pierre Michetti; Gian Dorta; Laurent Spahr; Emiliano Giostra; Jean Louis Frossard
Journal:  World J Gastroenterol       Date:  2012-05-07       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.